Intrinsiqq
Global Innovative Platforms Corp. logo

Global Innovative Platforms Corp. Financials

GIPL

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 7 available years
Income Statement
TTM
SEP 2025
~1.5:1 split
SEP 2024
43:1 split
SEP 2023
SEP 2022
SEP 2021
Revenues
Revenue$0$0$0$0$0$0
General & Administrative–$0$0$0$0$0
Research & Development$0$0$0–––
Total Operating Expenses$1$1$0$0$0$0
Operating Income-$1-$1-$0-$0-$0-$0
Other Non-Operating Income (Expense)––$0$0$0$0
EBT (Earnings Before Tax)-$1-$1-$0-$0-$0-$0
Income Tax Expense$0$0$0$0$0$0
Net Income
Net Income-$1-$1-$0-$0-$0-$0
Per Share Data
Revenue Per Share–$0.00$0.00$0.00$0.00$0.00
EPS (Basic)-$0.01-$0.02-$0.01-$0.46-$0.08-$0.12
EPS (Diluted)-$0.02-$0.02-$0.01-$0.46-$0.08-$0.12
Weighted Avg Shares (Basic)48.8M39.4M26.6M619,085619,085619,085
Weighted Avg Shares (Diluted)039.4M26.6M619,085619,085619,085
Shares Outstanding039.4M26.6M619,085619,085619,085

Global Innovative Platforms (GIPL) financials: revenue, profit and margins

Global Innovative Platforms (GIPL) generated about n/a in revenue and -$677,041.00 in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Global Innovative Platforms profitable?+

Global Innovative Platforms reported about -$677,041.00 in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 15 Aug 2026. How this is calculated.

Fiscal year ends Sep.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with GIPL

CompareIntrinsic value
AMIXAutonomix Medical Inc.
$0.89-14.32%20
NMTCNeuroOne Medical Technologies Corporation
$0.65-3.39%40
HRGNHarvard Apparatus Regenerative Technology Inc.
$1.90+4.11%10
PAVMPAVmed Inc.
$1.14-5.42%35
CODXCo-Diagnostics Inc.
$0.13-21.21%0
TNONTenon Medical Inc.
$0.90-9.01%40
LNSRLensar Inc.
$4.46-3.88%40
SSIISS Innovations International, Inc.
$1.27-0.78%30

Spot a number that looks wrong? Check it in GIPL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GIPL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.